Is GRX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GRX. It does not provide personalized investment advice.

GRX (The Gabelli Healthcare & Wellness Trust) Stock Analysis - Financials

The Gabelli Healthcare & Wellness Trust (GRX) is a publicly traded Financial Services sector company. As of October 1, 2026, GRX trades at $9.44 with a market cap of $138.32M and a P/E ratio of 0.00. GRX moved -0.95% today. Year to date, GRX is -2.23%; over the trailing twelve months it is +1.84%. Its 52-week range spans $8.80 to $10.23. Rallies surfaces GRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are GRX's key financials?

GRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GRX recently traded at $9.44. Market cap is $138.32M. P/E ratio is 0.00. Revenue is $0.

GRX Key Metrics

Key financial metrics for GRX
Metric	Value
Price	$9.44
Market Cap	$138.32M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.17%
52-Week High	$10.23
52-Week Low	$8.80
Volume	23.89K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

GRX Analyst Consensus

GRX analyst coverage data. Average price target: $0.00.

Common questions about GRX

What are GRX's key financials?: GRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GRX recently traded at $9.44. Market cap is $138.32M. P/E ratio is 0.00. Revenue is $0.
Is GRX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GRX. It does not provide personalized investment advice.